Archive · 27 Oct 2025
Ashish Dhawan Sells Shares of Glenmark and Greenlam
Imagine a smart investor named Ashish Dhawan, who's known for picking good stocks for the long haul.
He recently sold shares in two companies, Glenmark Pharmaceuticals and Greenlam Industries.
Glenmark makes medicines, and Dhawan held its shares for about six years.
Greenlam makes laminates and other products and Dhawan had it for about a decade.
Glenmark had a tough time making profits for a few years, but made a comeback recently, and its share price jumped.
Greenlam's sales are good, but its profits are not as good.
Although the reason for the exit is not public, it is worth watching these stocks to see what happens next.
Ashish Dhawan, a noted investor, sold shares of Glenmark Pharmaceuticals and Greenlam Industries.
Dhawan held Glenmark for around six years and Greenlam for about a decade.
Glenmark's share price increased 281% since October 2020.
Greenlam's share price jumped approximately 240% since October 2020.
HDFC MidCap Fund bought a stake in Glenmark, showing a different view from Dhawan.
- Who
- Ashish Dhawan, a smart investor.
- What
- Sold his holdings in Glenmark Pharmaceuticals and Greenlam Industries.
- When
- As per filings for the quarter ending September 2025.
- Where
- N/A
- Why
- Reasons for the exits are not explicitly stated, though profits appear to be a factor.
Dhawan's View
HDFC Midcap Fund's View
Glenmark Pharmaceuticals
Dhawan's View
Dhawan sold his shares, potentially indicating concerns about future performance.
HDFC Midcap Fund's View
HDFC MidCap Fund bought a 6.2% stake in the company, showing confidence in the company.
- Ashish Dhawan
- Sold shares in Glenmark and Greenlam
- Glenmark Pharma Market Cap
- Rs 52,216 cr
- Greenlam Industries Market Cap
- Rs 5,690 cr
- Glenmark Pharma Share Price (Oct 2020)
- Rs 485
- Greenlam Share Price (Oct 2020)
- Rs 76
- Greenlam PE
- 194x